Ailomics Therapeutics

digitalizes disease biology and 

delivers therapeutics of

significant clinical values.

 

 

 

  • R&D Model

     

     

     

     

     

    From bedside to bench and to bedside again.

     

    We start from patient samples and data, identify novel targets, develop human disease models, and discover FIC drug candidates, which are then tested back on the patients.

  • Business Models

     

     

     

     

     

    Internal R&D&C, co-development of therapeutics and companion diagnostics.

     

    We discover, develop and commercialize medicines. Meanwhile, we co-develop therapeutics with pharmaceutical MNCs and companion diagnostics with IVD companies.